Vasudev R Pai

Dr. Vasudev R Pai


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
VPVasudev R Pai
Vasudev R Pai
CSC. S Shreedhara
C. S Shreedhara
KCK. S. Chandrashekar
K. S. Chandrashekar
APAravinda Pai
Aravinda Pai
VKVenkatesh Kamath
Venkatesh Kamath

1 January 2017 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
VPVasudev R Pai
Vasudev R Pai
KCK. S Chandrashekar
K. S Chandrashekar
CSC. S. Shreedhara
C. S. Shreedhara
APAravinda Pai
Aravinda Pai

19 November 2025 in ACS Omega
Verified
Journal Article
Open access
MNMaria Nison
Maria Nison
MKMegha Kotian
Megha Kotian
VPVasudev R Pai
Vasudev R Pai
SBSony Priyanka Bandi
Sony Priyanka Bandi
PMPopat Mohite
Popat Mohite
DDDeepanjan Datta
Deepanjan Datta
Oral ulcers are a prevalent and recurrent condition that significantly impacts the patient’s quality of life by causing pain, discomfort, and difficulty in eating, speaking, and brushing their teeth. These ulcers can be triggered by diverse etiologies, from trauma to autoimmune disorders, which complicate their management, and they often require targeted treatment to promote healing and alleviate pain. Conventional treatments, such as corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and topical analgesics, among others, rely on synthetic medications that provide temporary relief and require frequent reapplication, thereby limiting their effectiveness. Thus, the management of oral ulcers necessitates the need for innovative therapeutic approaches. Recent advancements in nanotechnology and transdermal drug delivery have led to the development of dissolving microneedles (MNs) loaded with nanotherapeutics for delivering active therapeutics directly to affected oral tissues as a novel strategy for treating oral ulcers. Dissolving MNs offer a minimally invasive, painless, and efficient method for delivering therapeutic agents directly to the ulcer site, enhancing drug bioavailability, and ensuring sustained release. These biodegradable MNs dissolve upon application, eliminating the need for repeated drug application and thereby improving patient compliance. The synergistic approach of nanotherapeutics encapsulated within dissolving MNs, including nanoparticles, exosomes, and liposomes, among others, effectively addresses the multifactorial nature of oral ulcers by ensuring localized treatment and mitigating the systemic side effects associated with conventional drug delivery methods. Taken together, this review aims to integrate the current knowledge of these innovative technologies while highlighting future directions for research and clinical applications in treating oral ulcers.

1 January 2019 in Pharmacognosy Magazine
Verified
Journal Article
Closed access
PDF file
MSManganahalli Manjunath Setty
Manganahalli Manjunath Setty
VPVasudev R Pai
Vasudev R Pai
KCKs Chandrashekar
Ks Chandrashekar
PRPolu Picheshwara Rao
Polu Picheshwara Rao
Background: Preparation of highly standardized polyherbal formulation with its chief active chemical constituents supported by therapeutic efficacy in vitro is a valuable approach in the field of pharmaceutical sciences. Objective: The present work aims to develop the high-performance thin-layer chromatography (HPTLC) marker-based standardization of polyherbal formulation using Piperine, Asiaticoside, and Withanolide-A and in vitro acetylcholinesterase inhibition activity. Materials and Methods: For successful standardization, the HPTLC quantification of Piperine, Asiaticoside, and Withanolide-A was carried out. Suitable solvent systems were optimized to achieve the better resolution of the marker compounds, extracts, and sample formulation. The reproducibility of the methods was also confirmed by repeating the procedure twice. The identity of the bands in the sample formulation was confirmed by comparing the Rf value with those of their respective reference standards. In vitro acetylcholinesterase inhibition assay was done on the different crude extracts as well as tablet formulation. Results: HPTLC quantification of formulation for Piperine content showed 1.97% content w/w, whereas Piper longum extract showed 2.44% w/w. Similarly, Asiaticoside showed 0.71% in formulation and in Centella asiatica extract, it was 1.33% w/w. Contrary to the above, Withanolide-A content was 2.12% w/w in formulation and in Withania somnifera extract, it was only 0.81% w/w. In vitro acetylcholinesterase inhibition assay exhibited significant inhibition with IC50 value of 70 μg for tablet formulation. Conclusion: The presence of Piperine, Asiaticoside, and Withanolide-A in formulation was identified by rapid HPTLC quantification method. The method is very precise, reproducible, and accurate. The developed method can be used to quantify the marker compounds in the formulations available in the market. The formulation also evaluated for its acetylcholinesterase inhibition assay and showed significant activity. Hence, it could be used in the treatment of memory-related disorders such as Alzheimer's disease.

27 February 2026 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
PPPavithra Pradeep Prabhu
Pavithra Pradeep Prabhu
CLCynthia Lizzie Lobo
Cynthia Lizzie Lobo
LVL. B. Vishal
L. B. Vishal
ANAkhil Nair
Akhil Nair
APAravinda Pai
Aravinda Pai
Akhilesh DubeyAkhilesh Dubey
Akhilesh Dubey

1 January 2016 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
RRRohit Raj
Rohit Raj
KCK. S. Chandrashekar
K. S. Chandrashekar
RMRajalekshmi Maheshwari
Rajalekshmi Maheshwari
PPPicheswara Rao Polu
Picheswara Rao Polu
VPVasudev R Pai
Vasudev R Pai